EXCLUSIVE CO-PROMOTION AGREEMENTExclusive Co-Promotion Agreement • February 18th, 2011 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This Exclusive Co-Promotion Agreement (the "Agreement"), is entered into effective as of February 14, 2011 (the "Effective Date"), by and between QUINNOVA PHARMACEUTICALS, INC., a Delaware corporation, having an address of 411 South State Street, Third Floor, Newton, Pennsylvania 18940 ("QUINNOVA"), and OCULUS INNOVATIVE SCIENCES, INC., a Delaware corporation, having an address of 1129 North McDowell Boulevard, Petaluma, California 94954 ("OCULUS").
EXCLUSIVE SALES AND DISTRIBUTION AGREEMENTExclusive Sales and Distribution Agreement • February 18th, 2011 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This Exclusive Sales and Distribution Agreement is made and entered into as of the latest date set forth on the signature lines below (the “Effective Date”) by and between Oculus Innovative Sciences, Inc., a Delaware corporation having a place of business at 1129 North McDowell Boulevard, Petaluma, California, USA 94954 (“Oculus”); and Quinnova Pharmaceuticals, Inc., a Delaware corporation having a place of business at 411 South State Street, Newtown, Pennsylvania 18940 (“Quinnova”).
PRODUCT OPTION AGREEMENTProduct Option Agreement • February 18th, 2011 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • New York
This PRODUCT OPTION AGREEMENT (“Agreement”) is made and entered into as of the latest date set forth on the signature lines below (the “Effective Date”), by and between Oculus Innovative Sciences, Inc., a Delaware corporation having a place of business at 1129 North McDowell Boulevard, Petaluma, California 94954 (“OCULUS”); and AmDerma Pharmaceuticals, LLC, a Delaware limited liability company having a place of business at 440 US Highway 22 East, Suite 104, Bridgewater, New Jersey 08807 (“AmDerma”).
